Funded Tech Companies
Akribion Therapeutics
Based in Zwingenberg, Akribion Therapeutics has funding from Bruker, BMH Beteiligungs-Managementgesellschaft Hessen mbH and Carma Fund.
Company Overview
Company Name
Akribion Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Darmstädter Straße 34-36
Zwingenberg, 64673
Germany
Zwingenberg, 64673
Germany
Phone
Email Address
Company Background Information
Overview
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Our G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only if there is a highly specific match between the guide RNA and an intracellular RNA sequence, ensuring that only the targeted cells are affected, leaving healthy cells unharmed.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/4/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lukas Linnig
Company Investors
- Bruker
- BMH Beteiligungs-Managementgesellschaft Hessen mbH
- Carma Fund (Martin Raditsch)
- High-Tech Gründerfonds
Browse more funded tech companies:
Akoya Biosciences | Akriveia Therapeutics
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs